Moderna Inc (MRNA)

$54.35 +5.81 (11.97%)
Market Cap 21.57B
Revenue (ttm) 1.94B
Net Income (ttm) -2.82B
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -145.16%
Debt to Equity Ratio 0.08
Volume 20,925,799
Avg Vol 7,442,484
Day's Range N/A - N/A
Shares Out 396.79M
Stochastic %K 76%
Beta 1.05
Analysts Hold
Price Target $46.85

Company Profile

Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseas...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 714 6500
Address:
325 Binney Street, Cambridge, United States
MKScorpion83
MKScorpion83 May. 11 at 5:06 AM
$MRNA $LLY $SPY $QQQ With hantavirus possibly spreading leading to lockdowns, hospital workers all across the USA need to get prepared…. with some fresh dance moves.
0 · Reply
KingZack25
KingZack25 May. 11 at 4:48 AM
$MRNA
0 · Reply
VWAPVandal
VWAPVandal May. 11 at 4:36 AM
$MRNA Biotechnology company focused on mRNA-based healthcare and treatment-development technologies
0 · Reply
___dog___
___dog___ May. 11 at 3:46 AM
$NVAX $MRNA I think the rats passed it to the bats that passed it to the birds. The birds are flying around passing it to the humans. Duhhhh
1 · Reply
KingZack25
KingZack25 May. 11 at 3:43 AM
$MRNA nice Lil bull pennant consolidation overnight
0 · Reply
Rod92
Rod92 May. 11 at 3:18 AM
$MRNA hantavirus detected one week ago. But they left argentina april 1, so all that time they were infecting others. There is video of captain saying passenger died of nstiral causes, now we know that was before he knew hantavirus was a thing. Now all those people went on about their regular lives. This comes at all time highs for SPY. One thing i know, humans are stupid idiots and ignorance runs across. They didnt learn shit from covid.
0 · Reply
Rod92
Rod92 May. 11 at 3:15 AM
$MRNA everyone has to be careful for real.
0 · Reply
Rod92
Rod92 May. 11 at 3:11 AM
$MRNA not a scientist but i traded through covid, my points: - all these scientists all downplayed it - exam results take 1-2 months - no treatment or cure - incubatiom period 1-8 weeks - do NOT covid infection rates. - covid had 0.1% mortality rate, hantavirus has a 40% mortality rate. Covid got billions. - hantavirus gets 0.1% infection rate of 9B population means 40% pf those people die - you dont need a massive infection - all the scientists were wrong I don’t want nobody to die, but unfortunately, this is where it’s going.
0 · Reply
La_Parka3
La_Parka3 May. 11 at 3:11 AM
$MRNA I'm extremely bullish on Moderna and I think the hantavirus issue is a distraction. That said, it's about time this stock returns to its rightful place at the three digit!
0 · Reply
MKScorpion83
MKScorpion83 May. 11 at 2:50 AM
$MRNA $NVAX $SPY $QQQ
1 · Reply
Latest News on MRNA
How Hantavirus Made Moderna a Must-Own Stock Again

May 8, 2026, 2:44 PM EDT - 2 days ago

How Hantavirus Made Moderna a Must-Own Stock Again

Moderna (MRNA) Stock Surges 14% on Hantavirus Vaccine. Here’s What Investors Should Know

2026-05-08T18:07:45.000Z - 2 days ago

Moderna (MRNA) Stock Surges 14% on Hantavirus Vaccine. Here’s What Investors Should Know

Moderna Announces New England Journal of Medicine Publication of Pivotal Phase 3 Clinical Safety and Efficacy Data for Its Investigational Seasonal Influenza Vaccine, mRNA-1010

May 6, 2026, 5:15 PM EDT - 4 days ago

Moderna Announces New England Journal of Medicine Publication of Pivotal Phase 3 Clinical Safety and Efficacy Data for Its Investigational Seasonal Influenza Vaccine, mRNA-1010

Moderna's mRNA flu vaccine outperforms standard shot in late-stage trial

May 6, 2026, 5:01 PM EDT - 4 days ago

Moderna's mRNA flu vaccine outperforms standard shot in late-stage trial

Moderna Transcript: AGM 2026

May 6, 2026, 8:00 AM EDT - 4 days ago

Moderna Transcript: AGM 2026

Moderna updates on Cystic Fibrosis collaboration with Vertex Pharmaceuticals

2026-05-04T22:25:16.000Z - 6 days ago

Moderna updates on Cystic Fibrosis collaboration with Vertex Pharmaceuticals

VRTX

Moderna price target raised to $45 from $36 at UBS

2026-05-04T14:02:35.000Z - 6 days ago

Moderna price target raised to $45 from $36 at UBS

Moderna price target raised to $38 from $35 at RBC Capital

2026-05-04T13:02:40.000Z - 6 days ago

Moderna price target raised to $38 from $35 at RBC Capital

Moderna price target raised to $50 from $35 at Evercore ISI

2026-05-04T12:32:54.000Z - 6 days ago

Moderna price target raised to $50 from $35 at Evercore ISI

Moderna price target raised to $49 from $43 at Goldman Sachs

2026-05-01T23:45:44.000Z - 9 days ago

Moderna price target raised to $49 from $43 at Goldman Sachs

Moderna price target raised to $33 from $30 at Morgan Stanley

2026-05-01T17:15:49.000Z - 9 days ago

Moderna price target raised to $33 from $30 at Morgan Stanley

MRK

Moderna price target raised to $32 from $31 at BofA

2026-05-01T15:21:14.000Z - 9 days ago

Moderna price target raised to $32 from $31 at BofA

Moderna Earnings Call Transcript: Q1 2026

May 1, 2026, 8:00 AM EDT - 9 days ago

Moderna Earnings Call Transcript: Q1 2026

Moderna Stock Spikes After Earnings. Covid Vaccine Revenue Is a Growth Driver Again.

May 1, 2026, 7:46 AM EDT - 9 days ago

Moderna Stock Spikes After Earnings. Covid Vaccine Revenue Is a Growth Driver Again.

Moderna Reports Higher Revenue but Posts a Loss

May 1, 2026, 6:37 AM EDT - 9 days ago

Moderna Reports Higher Revenue but Posts a Loss

Moderna tops quarterly revenue estimates on stronger international COVID vaccine sales

May 1, 2026, 6:32 AM EDT - 9 days ago

Moderna tops quarterly revenue estimates on stronger international COVID vaccine sales

Moderna Reports First Quarter 2026 Financial Results and Provides Business Updates

May 1, 2026, 6:30 AM EDT - 9 days ago

Moderna Reports First Quarter 2026 Financial Results and Provides Business Updates

CureVac sues Moderna for patent infringement over COVID-19 vaccines

Apr 24, 2026, 4:52 PM EDT - 16 days ago

CureVac sues Moderna for patent infringement over COVID-19 vaccines

CVAC

Moderna starts late-stage trial of bird flu vaccine in US, UK

Apr 21, 2026, 7:13 PM EDT - 19 days ago

Moderna starts late-stage trial of bird flu vaccine in US, UK

Moderna Announces Initiation of Phase 3 Study of Investigational mRNA Pandemic Influenza Vaccine Candidate

Apr 21, 2026, 7:01 PM EDT - 19 days ago

Moderna Announces Initiation of Phase 3 Study of Investigational mRNA Pandemic Influenza Vaccine Candidate

Moderna Announces Data to be Presented at 2026 ASCO Annual Meeting

Apr 21, 2026, 10:00 AM EDT - 19 days ago

Moderna Announces Data to be Presented at 2026 ASCO Annual Meeting

Moderna wins EU approval for combined flu, COVID shot for older adults

Apr 21, 2026, 9:59 AM EDT - 19 days ago

Moderna wins EU approval for combined flu, COVID shot for older adults

Moderna Receives European Commission Marketing Authorization for mCOMBRIAX, Moderna's mRNA Combination Vaccine Against Influenza and COVID-19

Apr 21, 2026, 9:40 AM EDT - 19 days ago

Moderna Receives European Commission Marketing Authorization for mCOMBRIAX, Moderna's mRNA Combination Vaccine Against Influenza and COVID-19

Moderna to Present at Upcoming Conferences in May 2026

Apr 21, 2026, 7:00 AM EDT - 19 days ago

Moderna to Present at Upcoming Conferences in May 2026

Moderna to Present Phase 1/2 Data on Its Investigational Cancer Antigen Therapy mRNA-4359 as First-Line Therapy in Combination with Pembrolizumab in Locally Advanced or Metastatic Melanoma at the 2026 AACR Annual Meeting

Apr 17, 2026, 3:00 PM EDT - 23 days ago

Moderna to Present Phase 1/2 Data on Its Investigational Cancer Antigen Therapy mRNA-4359 as First-Line Therapy in Combination with Pembrolizumab in Locally Advanced or Metastatic Melanoma at the 2026 AACR Annual Meeting

Moderna to Report First Quarter 2026 Financial Results on Friday, May 1, 2026

Apr 15, 2026, 7:00 AM EDT - 25 days ago

Moderna to Report First Quarter 2026 Financial Results on Friday, May 1, 2026

Moderna to Present Revaccination Data for Its Investigational Seasonal Influenza Vaccine and for mRESVIA at ESCMID 2026

Apr 6, 2026, 6:01 PM EDT - 4 weeks ago

Moderna to Present Revaccination Data for Its Investigational Seasonal Influenza Vaccine and for mRESVIA at ESCMID 2026

Moderna Transcript: Barclays 28th Annual Global Healthcare Conference

Mar 10, 2026, 9:30 AM EDT - 2 months ago

Moderna Transcript: Barclays 28th Annual Global Healthcare Conference

FDA reversals leave investors worrying about the fates of other experimental drugs

Mar 6, 2026, 11:33 AM EST - 2 months ago

FDA reversals leave investors worrying about the fates of other experimental drugs

DNLI RGNX WVE

Moderna rises as up to $2.25 billion settlement for COVID vaccine patent dispute to remove overhang

Mar 4, 2026, 8:26 AM EST - 2 months ago

Moderna rises as up to $2.25 billion settlement for COVID vaccine patent dispute to remove overhang

Moderna Stock Rallies. This Big Risk Just Got Eliminated.

Mar 4, 2026, 5:25 AM EST - 2 months ago

Moderna Stock Rallies. This Big Risk Just Got Eliminated.

Moderna's stock rallies more than 10% as deal over a patent dispute clears vaccine pipeline

Mar 3, 2026, 5:30 PM EST - 2 months ago

Moderna's stock rallies more than 10% as deal over a patent dispute clears vaccine pipeline

Moderna to Pay $950 Million to Settle Patent Cases From Arbutus, Genevant

Mar 3, 2026, 4:46 PM EST - 2 months ago

Moderna to Pay $950 Million to Settle Patent Cases From Arbutus, Genevant

ABUS

Moderna agrees to pay up to $2.25 billion to settle COVID vaccine patent dispute

Mar 3, 2026, 4:26 PM EST - 2 months ago

Moderna agrees to pay up to $2.25 billion to settle COVID vaccine patent dispute

ABUS ROIV

Roivant Announces Genevant Sciences' and Arbutus Biopharma's $2.25 Billion Global Settlement With Moderna

Mar 3, 2026, 4:15 PM EST - 2 months ago

Roivant Announces Genevant Sciences' and Arbutus Biopharma's $2.25 Billion Global Settlement With Moderna

ABUS ROIV

Genevant Sciences and Arbutus Biopharma Announce $2.25 Billion Global Settlement With Moderna

Mar 3, 2026, 4:15 PM EST - 2 months ago

Genevant Sciences and Arbutus Biopharma Announce $2.25 Billion Global Settlement With Moderna

ABUS ROIV

Moderna Resolves Global Patent Litigation with Arbutus/Genevant

Mar 3, 2026, 4:15 PM EST - 2 months ago

Moderna Resolves Global Patent Litigation with Arbutus/Genevant

ABUS

Moderna Transcript: TD Cowen 46th Annual Health Care Conference

Mar 3, 2026, 1:50 PM EST - 2 months ago

Moderna Transcript: TD Cowen 46th Annual Health Care Conference

Moderna's Covid-Flu Vaccine Recommended for Approval in EU

Feb 27, 2026, 7:23 AM EST - 2 months ago

Moderna's Covid-Flu Vaccine Recommended for Approval in EU

European Medicines Agency's Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Marketing Authorization of mCOMBRIAX, Moderna's mRNA Combination Vaccine Against Influenza and COVID-19

Feb 27, 2026, 7:00 AM EST - 2 months ago

European Medicines Agency's Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Marketing Authorization of mCOMBRIAX, Moderna's mRNA Combination Vaccine Against Influenza and COVID-19

Moderna gets EU regulator nod for combined COVID, flu vaccine

Feb 27, 2026, 6:09 AM EST - 2 months ago

Moderna gets EU regulator nod for combined COVID, flu vaccine

Moderna Stock: How Far Can The Flu Shot Fly?

Feb 24, 2026, 10:40 AM EST - 2 months ago

Moderna Stock: How Far Can The Flu Shot Fly?

US FDA Commissioner Makary says FDA supports mRNA vaccines but US taxpayers should not bear the cost

Feb 23, 2026, 3:15 PM EST - 2 months ago

US FDA Commissioner Makary says FDA supports mRNA vaccines but US taxpayers should not bear the cost

MRK PFE

BioNTech sues Moderna for patent infringement over COVID-19 shots

Feb 19, 2026, 1:25 PM EST - 2 months ago

BioNTech sues Moderna for patent infringement over COVID-19 shots

BNTX

Moderna to Present at Upcoming Conferences in March 2026

Feb 19, 2026, 7:00 AM EST - 2 months ago

Moderna to Present at Upcoming Conferences in March 2026

FDA agrees to review Moderna's mRNA flu vaccine application in a reversal

Feb 18, 2026, 11:17 AM EST - 2 months ago

FDA agrees to review Moderna's mRNA flu vaccine application in a reversal

Moderna Shares Rally 6% After FDA Reverses Decision Not To Review Flu Vaccine

Feb 18, 2026, 11:00 AM EST - 2 months ago

Moderna Shares Rally 6% After FDA Reverses Decision Not To Review Flu Vaccine

Moderna got the FDA to change its mind and review its flu vaccine after some concessions

Feb 18, 2026, 10:22 AM EST - 2 months ago

Moderna got the FDA to change its mind and review its flu vaccine after some concessions

FDA reverses decision not to review Moderna's new flu vaccine

Feb 18, 2026, 9:35 AM EST - 2 months ago

FDA reverses decision not to review Moderna's new flu vaccine

Moderna Says FDA Will Review Its Flu Vaccine. The Stock Is Rising.

Feb 18, 2026, 9:27 AM EST - 2 months ago

Moderna Says FDA Will Review Its Flu Vaccine. The Stock Is Rising.

The FDA reversed course and agreed to begin a review of Moderna's seasonal flu shot

Feb 18, 2026, 9:12 AM EST - 2 months ago

The FDA reversed course and agreed to begin a review of Moderna's seasonal flu shot

Health Rounds: Moderna combo flu/COVID vaccine succeeds in mid-stage trial

Feb 18, 2026, 7:13 AM EST - 2 months ago

Health Rounds: Moderna combo flu/COVID vaccine succeeds in mid-stage trial

US FDA to initiate review of Moderna's influenza vaccine

Feb 18, 2026, 7:07 AM EST - 2 months ago

US FDA to initiate review of Moderna's influenza vaccine

Moderna Announces the U.S. Food and Drug Administration will Initiate the Review of Its Investigational Seasonal Influenza Vaccine Submission

Feb 18, 2026, 7:00 AM EST - 2 months ago

Moderna Announces the U.S. Food and Drug Administration will Initiate the Review of Its Investigational Seasonal Influenza Vaccine Submission

Moderna Receives European Commission Marketing Authorization for COVID-19 Vaccine mNEXSPIKE

Feb 17, 2026, 7:00 AM EST - 2 months ago

Moderna Receives European Commission Marketing Authorization for COVID-19 Vaccine mNEXSPIKE

Moderna, Inc. (MRNA) Price Forecast: Breakout Signals New Bull Trend

Feb 13, 2026, 4:53 PM EST - 3 months ago

Moderna, Inc. (MRNA) Price Forecast: Breakout Signals New Bull Trend

MRNA Starts 2026 Volatile: Examining Rally & Pullback, Outsized Options

Feb 13, 2026, 4:13 PM EST - 3 months ago

MRNA Starts 2026 Volatile: Examining Rally & Pullback, Outsized Options

Moderna Earnings Call Transcript: Q4 2025

Feb 13, 2026, 8:00 AM EST - 3 months ago

Moderna Earnings Call Transcript: Q4 2025

Moderna Narrows Loss, Reiterates 10% Revenue Growth Target

Feb 13, 2026, 7:56 AM EST - 3 months ago

Moderna Narrows Loss, Reiterates 10% Revenue Growth Target

Moderna Reports a Narrower-Than-Expected Loss. The Stock Falls After Earnings.

Feb 13, 2026, 7:13 AM EST - 3 months ago

Moderna Reports a Narrower-Than-Expected Loss. The Stock Falls After Earnings.

Moderna beats fourth-quarter revenue estimates

Feb 13, 2026, 7:06 AM EST - 3 months ago

Moderna beats fourth-quarter revenue estimates

Moderna Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Business Updates

Feb 13, 2026, 7:00 AM EST - 3 months ago

Moderna Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Business Updates

Moderna Stock Sports Technical Support Ahead Of Earnings

Feb 12, 2026, 3:25 PM EST - 3 months ago

Moderna Stock Sports Technical Support Ahead Of Earnings

MKScorpion83
MKScorpion83 May. 11 at 5:06 AM
$MRNA $LLY $SPY $QQQ With hantavirus possibly spreading leading to lockdowns, hospital workers all across the USA need to get prepared…. with some fresh dance moves.
0 · Reply
KingZack25
KingZack25 May. 11 at 4:48 AM
$MRNA
0 · Reply
VWAPVandal
VWAPVandal May. 11 at 4:36 AM
$MRNA Biotechnology company focused on mRNA-based healthcare and treatment-development technologies
0 · Reply
___dog___
___dog___ May. 11 at 3:46 AM
$NVAX $MRNA I think the rats passed it to the bats that passed it to the birds. The birds are flying around passing it to the humans. Duhhhh
1 · Reply
KingZack25
KingZack25 May. 11 at 3:43 AM
$MRNA nice Lil bull pennant consolidation overnight
0 · Reply
Rod92
Rod92 May. 11 at 3:18 AM
$MRNA hantavirus detected one week ago. But they left argentina april 1, so all that time they were infecting others. There is video of captain saying passenger died of nstiral causes, now we know that was before he knew hantavirus was a thing. Now all those people went on about their regular lives. This comes at all time highs for SPY. One thing i know, humans are stupid idiots and ignorance runs across. They didnt learn shit from covid.
0 · Reply
Rod92
Rod92 May. 11 at 3:15 AM
$MRNA everyone has to be careful for real.
0 · Reply
Rod92
Rod92 May. 11 at 3:11 AM
$MRNA not a scientist but i traded through covid, my points: - all these scientists all downplayed it - exam results take 1-2 months - no treatment or cure - incubatiom period 1-8 weeks - do NOT covid infection rates. - covid had 0.1% mortality rate, hantavirus has a 40% mortality rate. Covid got billions. - hantavirus gets 0.1% infection rate of 9B population means 40% pf those people die - you dont need a massive infection - all the scientists were wrong I don’t want nobody to die, but unfortunately, this is where it’s going.
0 · Reply
La_Parka3
La_Parka3 May. 11 at 3:11 AM
$MRNA I'm extremely bullish on Moderna and I think the hantavirus issue is a distraction. That said, it's about time this stock returns to its rightful place at the three digit!
0 · Reply
MKScorpion83
MKScorpion83 May. 11 at 2:50 AM
$MRNA $NVAX $SPY $QQQ
1 · Reply
wintogether
wintogether May. 11 at 2:37 AM
$NVAX why are people developing symptoms of infection if the rodents were not on the ship? Were just infected passengers who brought the virus from being infected on land infecting others even without close contact? $MRNA https://www.yahoo.com/news/world/live/hantavirus-latest-updates-passengers-begin-disembarking-cruise-ship-off-spains-canary-islands-195033914.html
2 · Reply
Jerry5012
Jerry5012 May. 11 at 2:20 AM
$MRNA Wow where do we open at baby
0 · Reply
Kevin73ca
Kevin73ca May. 11 at 1:43 AM
$MRNA I bought little qty at 40 I didn’t thought this will run that fast according yo hantavirus
0 · Reply
MoonShotGMoney
MoonShotGMoney May. 11 at 1:43 AM
$MRNA open $60!
0 · Reply
jwordlek
jwordlek May. 11 at 1:43 AM
$MRNA please stay below 56. Someone sold 56$ calls expiring 5/15 for 3.10. So, I followed but at lower premium.
0 · Reply
Scalptrades101
Scalptrades101 May. 11 at 1:34 AM
$SPY I think $MRNA and $LLY looked ready to move up before this news, extra bullish with virus
0 · Reply
Themadogtrader
Themadogtrader May. 11 at 1:33 AM
$MRNA new death jabs coming fuck your grandma let’s make money off of it 💯
0 · Reply
Socrates69
Socrates69 May. 11 at 1:30 AM
$MRNA Watch to see if Hanta becomes a real threat $QQQ $SPY $DIA
1 · Reply
SqueezeTease
SqueezeTease May. 11 at 1:08 AM
$MRNA 💉💉💉💉🦠
1 · Reply
DreamChaser23
DreamChaser23 May. 11 at 12:29 AM
$MRNA
1 · Reply
doggo991
doggo991 May. 11 at 12:23 AM
$BTC.X Still had time to short it when reached 82k … It’s going back to 78k-ish … or lover. Bulls are cooked … $SPY $WLFI.X $MRNA
2 · Reply
tdyck15
tdyck15 May. 11 at 12:11 AM
$MRNA I’ve been investing a long time and I just find it so crazy how every time the market seems overheated, there is ALWAYS something to cause a correction. This time might be the Hantavirus.
1 · Reply